IMR Press / CEOG / Volume 28 / Issue 3 / pii/2001041

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Editorial

The immunolocalization of Bcl-2 in human term placenta

Show Less
1 Department of Obstetrics and Gynecology, Medical School, University of the Saarland, Homburg/Saar (Germany)
2 Department of Pathology, Medical School, University of the Saarland, Homburg/Saar (Germany)
Clin. Exp. Obstet. Gynecol. 2001, 28(3), 144–147;
Published: 10 September 2001
Abstract

Purpose: To study the immunolocalization of the Bcl-2 protein in formalin-fixed placental tissue collected from uncomplicated term pregnancies.

Methods: A total of 19 human term placentas of 38-41 weeks’ gestation, 11 obtained from spontaneous deliveries and eight from elective caesarean sections prior to labour were included. Sections were incubated with an antibody to the Bcl-2 protein and light microscopy was used to evaluate Bcl-2 staining. Results: The anti-apoptotic Bcl-2 protein was expressed diffusely throughout the cytoplasm of the syncytiotrophoblast with much less intensive staining in cytotrophoblast and mesenchymal cells. Bcl-2 expression was reduced or lost in areas of syncytial sprouts. No differences in Bcl-2 staining were observed between placentas obtained after spontaneous deliveries and those collected before the onset of labour after elective caesarean section. Conclusion: Expression of the anti-apoptotic Bcl-2 protein in human term placenta does not seem to be influenced by parturition. Additionally, Bcl-2 expression might be an important factor in the regulation of apoptosis in the human trophoblast and thus in maintaining placental function during gestation.

Keywords
Bcl-2 expression
Placenta
Immunohistochernistry
Share
Back to top